The impact of home nocturnal hemodialysis on end-stage renal disease therapies: A decision analysis

Kidney International

Volumn 69, Issue 5, 2006, Pages 798-805

  McFarlane, P A ^a   Bayoumi, A M ^a   Pierratos, A ^b   Redelmeier, D A ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b HUMBER RIVER REGIONAL HOSPITAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Cost effectiveness; Decision analysis; Economic analysis; Hemodialysis; Hemodialysis, home; Resource allocation

Indexed keywords

ANALYTIC METHOD; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION ANALYSIS; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH INSURANCE; HEMODIALYSIS; HOME NOCTURNAL HEMODIALYSIS; HUMAN; IN CENTER HEMODIALYSIS; INTERMETHOD COMPARISON; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; LIFESPAN; LIVING DONOR; MONTE CARLO METHOD; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; REVIEW; SENSITIVITY ANALYSIS; STATISTICAL MODEL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TREATMENT INDICATION;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HEMODIALYSIS, HOME; HUMANS; KIDNEY FAILURE, CHRONIC; MARKOV CHAINS; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 33644504240     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ki.5000059     Document Type: Review

References (67)

1. Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Ann Intern Med 1994; 121: 62-70.
2. Krolewski M, Eggers PW, Warram JH. Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study [published erratum appears in Kidney Int 1997; 51(3): 978]. Kidney Int 1996; 50: 2041-2046.
3. Weller JM, Port FK, Swartz RD et al. Analysis of survival of end-stage renal disease patients. Kidney Int 1982; 21: 78-83.
4. United States Renal Data System. The USRDS Dialysis Morbidity and Mortality Study: Wave 2. Am J Kidney Dis 1997; 30: S67-S85.
5. United States Renal Data System. USRDS 1999 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 1999.
6. Campbell JD, Campbell AR. The social and economic cost of end-stage renal disease. A patient's perspective. N Engl J Med 1978; 299: 386-392.
7. Canadian Organ Replacement Registry (CORR). Canadian Organ Replacement Registry (CORR): 2001 Annual Report. Canadian Institute for Health Information: Ottawa, ON, Canada, 2001.
8. Bell CM, Chapman RH, Stone PW et al. An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses. Med Decision Making 2001; 21: 288-294.
9. Renal Physicians Association. Appropriate patient preparation for renal replacement therapy. In: Renal Physicians Association Clinical Practice Guidelines. Duke Evidence-Based Practice Center, Center for Clinical Health Policy Research: Durham, NC, 2002, p 11.
10. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
11. Hunsicker LG. A survival advantage for renal transplantation. N Engl J Med 1999; 341: 1762.
12. Laupacis A, Keown P, Pus N et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242.
13. Arend SM, Mallat MJ, Westendorp RJ et al. Patient survival after renal transplantation; more than 25 years follow-up. Nephrol Dial Transplant 1997; 12: 1672-1679.
14. Buoncristiani U, Quintaliani G, Cozzari M et al. Daily dialysis: long-term clinical metabolic results. Kidney Int Suppl 1988; 24: S137-S140.
15. Laurent G, Calemard E, Charra B. Long dialysis: a review of fifteen years experience in one centre 1968-1983. Proc Eur Dial Transplant Assoc 1983; 20: 122-135.
16. Laurent G, Charra B. The results of an 8 h thrice weekly haemodialysis schedule. Nephrol Dial Transplant 1998; 13: 125-131.
17. Shaldon S, Oakley JJ. Experience with regular haemodialysis in the home. Br J Urol 1966; 38: 616-620.
18. McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 2002; 62: 2216-2222.
19. McFarlane PA, Bayoumi AM, Pierratos A et al. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 2003; 64: 1004-1011.
20. Woods JD, Port FK, Stannard D et al. Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int 1996; 49: 1464-1470.
21. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996; 49: 1215-1219.
22. Redelmeier DA, Goldstein RS, Min ST et al. Spirometry and dyspnea in patients with COPD. When small differences mean little. Chest 1996; 109: 1163-1168.
23. Gold MR, Siegel JE, Russell LB et al. Cost-Effectiveness in Health and Medicine. Oxford University Press: Oxford, 1996.
24. Lee H, Manns B, Taub K et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 2002; 40: 611-622.
25. McFarlane PA. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin Dial 2004; 17: 118-124.
26. Goeree R, Manalich J, Grootendorst P et al. Cost analysis of dialysis treatments for end-stage renal disease (ESRD). Clin Invest Med 1995; 18: 455-464.
27. Douglas RA. The costs of kidney transplantation and hemodialysis. Transplant Proc 1973; 5: 1043-1046.
28. Stewart JH, Topp ND, Martin S et al. The costs of domiciliary maintenance haemodialysis. A comparison with alternative renal replacement regimens. Med J Aust 1973; 1: 156-159.
29. Buxton MJ, West RR. Cost-benefit analysis of long-term haemodialysis for chronic renal failure. Br Med J 1975; 2: 376-379.
30. Hoffstein PA, Krueger KK, Wineman RJ. Dialysis costs: results of a diverse sample study. Kidney Int 1976; 9: 286-293.
31. Schippers HM, Kalff MW. Cost comparison haemodialysis and renal transplantation. Tissue Antigens 1976; 7: 86-90.
32. Bulgin RH. Comparative costs of various dialysis treatments. Periton Dial Bull 1981; 1: 88-91.
33. Roberts SD, Maxwell DR, Gross TL. Are home hemodialysis aides cost-effective? Cost of home hemodialysis aides. Arch Intern Med 1981; 141: 855-858.
34. Roberts SD, Maxwell DR, Gross TL. Cost-effective care of end-stage renal disease: a billion dollar question. Ann Intern Med 1980; 92: 243-248.
35. Stange PV, Sumner AT. Predicting treatment costs and life expectancy for end-stage renal disease. N Engl J Med 1978; 298: 372-378.
36. Churchill DN, Lemon BC, Torrance GW. A cost-effectiveness analysis of continuous ambulatory perioneal dialysis and hospital hemodialysis. Med Decision Making 1984; 4: 489-500.
37. Churchill DN, Torrance GW, Taylor DW et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 1987; 10: 14-20.
38. Churchill DN, Wallace JE, Ludwin D et al. A comparison of evaluative indices of quality of life and cognitive function in hemodialysis patients. Controlled Clin Trials 1991; 12: 159S-167S.
39. Garner TI, Dardis R. Cost-effectiveness analysis of end-stage renal disease treatments. Med Care 1987; 25: 25-34.
40. Tousignant P, Guttmann RD, Hollomby DJ. Transplantation and home hemodialysis: their cost-effectiveness. J Chronic Dis 1985; 38: 589-601.
41. Croxson BE, Ashton T. A cost effectiveness analysis of the treatment of end stage renal failure. NZ Med J 1990; 103: 171-174.
42. Sesso R, Eisenberg JM, Stabile C et al. Cost-effectiveness analysis of the treatment of end-stage renal disease in Brazil. Int J Technol Assess Health Care 1990; 6: 107-114.
43. Karlberg I, Nyberg G. Cost-effectiveness studies of renal transplantation. Int J Technol Assess Health Care 1995; 11: 611-622.
44. Karlberg I. Cost analysis of alternative treatments in end-stage renal disease. Transplant Proc 1992; 24: 335.
45. Coyte PC, Young LG, Tipper BL et al. An economic evaluation of hospital-based hemodialysis and home-based peritoneal dialysis for pediatric patients. Am J Kidney Dis 1996; 27: 557-565.
46. Rodriguez-Carmona A, Perez FM, Bouza P et al. The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit. Adv Periton Dial 1996; 12: 93-96.
47. Prichard SS. The costs of dialysis in Canada [Review] [2 refs]. Nephrol Dial Transplant 1997; 12(Suppl 1): 22-24.
48. Heidenheim AP, Muirhead N, Moist L et al. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003; 42: 36-41.
49. Kjellstrand C, Ting G. Daily hemodialysis: dialysis for the next century. Adv Renal Replace Ther 1998; 5: 267-274.
50. Brissenden JE, Pierratos A, Ouwendyk M et al. Improvements in quality of life with nocturnal hemodialysis. J Am Soc Nephrol 1998; 9: 168A.
51. Traeger J, Galland R, Arkouche W et al. Short daily hemodialysis: a four-year experience. Dial Transplant 2001; 30: 76-86.
52. Ting G, Freitas T, Carrie BJ et al. Short daily hemodialysis - clinical outcomes and quality of life. J Am Soc Nephrol 1999; 9: 228A.
53. Ting GO. The case for short daily hemodialysis, why sDHD will be the predominant modality for frequent dialysis. ASAIO J 2001; 47: 443-445.
54. Mohr PE. The economics of daily dialysis. Adv Renal Replace Ther 2001; 8: 273-279.
55. Mohr PE, Neumann PJ, Franco SJ et al. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis (Online) 2001; 37: 777-789.
56. Mohr PE, Neumann PJ, Franco SJ et al. The quality of life and economic implications of daily dialysis. Policy Anal Brief H Ser 1999; 1: 1-4.
57. Lacson Jr E, Diaz-Buxo JA. Daily and nocturnal hemodialysis: how do they stack up? Am J Kidney Dis 2001; 38: 225-239.
58. Kooistra MP, Vos J, Koomans HA et al. Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998; 13: 2853-2860.
59. Robers S. Cost of daily hemodialysis. Asaio J 2001; 47: 459-461.
60. Simoons ML, Vos J, Martens LL. Cost-utility analysis of thrombolytic therapy. Eur Heart J 1991; 12: 694-699.
61. Levin LA, Jonsson B. Cost-effectiveness of thrombolysis - a randomized study of intravenous rt-PA in suspected myocardial infarction. Eur Heart J 1992; 13: 2-8.
62. Kroeker A, Clark WF, Heidenheim AP et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 2003; 42: 49-55.
63. Anonymous. Mortality rate comparisons of never, previously, and currently transplanted ESRD patients. Am J Kidney Dis 1992; 20: 55-60.
64. Cecka JM. The UNOS renal transplant registry. Clin Transplants 2001: 1-18.
65. Cecka JM. The LINOS scientific renal transplant registry. Clin Transplants 1996: 1-14.
66. Cecka M. Clinical outcome of renal transplantation. Factors influencing patient and graft survival. Surg Clin N Am 1998; 78: 133-148.
67. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001; 10: 779-787.